| CEO Name | Robert G. Kramer |
| Nationality | United States |
| Net Worth Estimation | $50 million |
Robert G. Kramer, CEO of Emergent BioSolutions Inc., has an estimated net worth of around $50 million primarily from his long-term executive compensation, stock awards, and performance-based bonuses linked to company milestones and share price growth. His financial profile is further influenced by vested stock options and additional income from board memberships and strategic business activities.
Robert G. Kramer, CEO of Emergent BioSolutions Inc., has an estimated net worth of $50,000,000, positioning him at the midpoint within the healthcare sector's CEO net worth range of $10,000,000 to $90,000,000. His net worth represents roughly 56% of the maximum estimated CEO net worth in this business category.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Robert G. Kramer Performance in Emergent BioSolutions Inc.
Robert G. Kramer, CEO of Emergent BioSolutions Inc., demonstrates strategic leadership by driving innovation and operational excellence in biopharmaceuticals. His decisive actions in streamlining vaccine production and expanding the company's biodefense portfolio have significantly enhanced corporate performance. Under Kramer's leadership, Emergent BioSolutions achieved robust growth and strengthened its position in public health preparedness and biodefense markets.
Latest News
Emergent BioSolutions Appoints Joseph C. Papa as New CEO
Emergent BioSolutions Inc. announced Joseph C. Papa as its new president and CEO, effective February 21, 2024, following a thorough board search. Papa, a seasoned pharmaceutical executive, is tasked with leading the company's transformation, focusing on public health, growth, and debt reduction.
Source: http://www.biospace.com/emergent-biosolutions-appoints-industry-leader-joseph-c-papa-as-new-president-and-ceo